Clinical Trial Update: Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Fluticasone (fluticasone propionate)

Snippet

Sponsor: University of Utah | Conditions: Esophagitis | Phase 2 | Status: COMPLETED